From left, Frank Huang, marketing director of Ascletis Pharma, CEO Jinzi Jason Wu and vice-president Yi Chen, at the company’s IPO press conference in Hong Kong on July 19. Photo: Jonathan Wong

Asia’s first pre-profit biotech listing Ascletis Pharma ends unchanged in debut trade

Topic |   Stocks

TOP PICKS

From left, Frank Huang, marketing director of Ascletis Pharma, CEO Jinzi Jason Wu and vice-president Yi Chen, at the company’s IPO press conference in Hong Kong on July 19. Photo: Jonathan Wong
READ FULL ARTICLE